Mutations in the Plasmodium falciparum genes, pfdhfr and pfdhps, drive antifolate resistance and threaten malaria control in regions where sulfadoxine-pyrimethamine (SP) is the primary chemoprevention strategy. The spatial patterns and evolutionary dynamics of these mutations in high-transmission settings remain incomp...
V. Asua, K. Niaré, Shreeya Garg et al.· Nature Communications· 1 citation
Genomic tools can support malaria control policy through surveillance of Plasmodium falciparum populations, tracking antimalarial drug resistance, pfhrp2/3 deletions that compromise rapid diagnostic tests, and selection at the circumsporozoite protein (PfCSP) vaccine target, as well as through molecular correction of t...
Francis D. Semakuba, B. Nsengimaana, Monica Mbabazi et al.· bioRxiv· 0 citations
Artemisinin-based combination therapies are the cornerstone of malaria treatment and control. In Africa, artemether–lumefantrine is the most widely used first-line artemisinin-based combination therapy, but its efficacy in Uganda is increasingly threatened by the emergence of artemisinin partial resistance and reduced...
K. Niaré, Bersabeh Tafesse, Mayland Treat et al.· Nature Medicine· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.